NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
Back to search
Official data from USPTO
TERRA BIOFORGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TERRA BIOFORGE
ST13
US500000098251667Class
1, 5, 40, 42
Filing
98251667
Registration
7692478
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
02/18/2025
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
11/02/2023
Registration date
02/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/19/2023
First use in commerce
06/21/2023
Drawing code
4
Owner type
03
Owner location
Middleton, WI
Examiner
ALESKOW, DAVID
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TERRA BIOWORKS, INC.
Representatives
Thomas A. Isenbarger CASIMIR JONES, S.C.
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Engineered microbes for use in the manufacture of nucleic acidsproteinschemicals for researchindustryscienceagriculture; engineered microbes for use in the manufacture of therapeutic pharmaceuticals for medical and veterinary purposes; molecular biology reagents and kits consisting of enzymescloning vectorscellsnucleic acids for scientific and research use in the field of synthetic biology; proteins for use in the manufacture of therapeutic pharmaceuticals for medical and veterinary purposes
Class 5
Nucleic acids for use in the production of therapeutic pharmaceuticals for medical and veterinary purposes; pharmaceutical compounds for the treatment of microbial infectionsviral infectionsfungal infectionscancer
Class 40
Production of genetically engineered nucleic acidsproteinsbiological organisms for others
Class 42
Scientific research services in the fields of synthetic biologynatural productsgenetic engineeringbiotechnologybiological engineering; laboratory research services in the field of synthetic biologynatural productsgenetic engineeringbiotechnologybiological engineering
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/25/2024
GNRT
NON-FINAL ACTION E-MAILED
11/25/2024
CNRT
NON-FINAL ACTION WRITTEN
11/25/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/22/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2024
GNRT
NON-FINAL ACTION E-MAILED
06/25/2024
CNRT
NON-FINAL ACTION WRITTEN
06/25/2024
DOCK
ASSIGNED TO EXAMINER
06/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
NWAP
NEW APPLICATION ENTERED
11/06/2023
Continuous trademark protection
Get notified about every new filing that threatens TERRA BIOFORGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.